Global cancer statistics, CA Cancer J Clin, vol.61, pp.69-90, 2011. ,
, Goggins M. Pancreatic cancer. Lancet, vol.378, pp.607-620, 2011.
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States, Cancer Res, 2014. ,
, , vol.74, pp.2913-2934
Pancreatic adenocarcinoma: new strategies for success, Gastrointest Cancer Res, vol.3, pp.11-15, 2009. ,
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N Engl J Med, vol.364, pp.1817-1825, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00598658
DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition, Chem Rev, vol.109, pp.2894-2902, 2009. ,
Pharmacogenetic pathway analysis of irinotecan, Clin Pharmacol Ther, vol.84, pp.393-402, 2008. ,
ABC multidrug transporters: structure, function and role in chemoresistance, Pharmacogenomics, vol.9, pp.105-127, 2008. ,
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis, Oncogene, vol.26, pp.6469-6487, 2007. ,
Copy number of chromosome 17 but not HER2 amplification predicts clinical outcome of patients with pancreatic ductal adenocarcinoma, J Clin Oncol, vol.22, pp.4737-4745, 2004. ,
HER2 overexpression correlates with survival after curative resection of pancreatic cancer, Cancer Sci, vol.100, pp.1243-1247, 2009. ,
Van Seuningen I. The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways, PLoS One, vol.7, p.32232, 2012. ,
The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family, Oncogene, vol.32, pp.1714-1723, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00807837
The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38, Int J Cancer, vol.125, pp.2957-2969, 2009. ,
Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell lines, Anticancer Drugs, vol.20, pp.918-925, 2009. ,
Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3, Mol Cell, vol.23, pp.121-132, 2006. ,
Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment, Cancer Lett, vol.285, pp.58-65, 2009. ,
Trastuzumab has opposing effects on SN-38-induced double-strand breaks and cytotoxicity in HER2-positive gastric cancer cells depending on administration sequence, Anticancer Res, vol.32, pp.105-114, 2012. ,
Topoisomerase I inhibitors: camptothecins and beyond, Nat Rev Cancer, vol.6, pp.789-802, 2006. ,
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine, Biochim Biophys Acta, vol.1853, pp.89-100, 2015. ,
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis, Apoptosis, vol.18, pp.337-346, 2013. ,
p53 status determines the role of autophagy in pancreatic tumour development, Nature, vol.504, pp.296-300, 2013. ,
Van Seuningen I. Of autophagy and in vivo pancreatic carcinogenesis: the p53 status matters, Clin Res Hepatol Gastroenterol, vol.38, pp.423-425, 2014. ,
ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss, Autophagy, vol.10, pp.662-676, 2014. ,
Signal integration by JNK and p38 MAPK pathways in cancer development, Nat Rev Cancer, vol.9, pp.537-549, 2009. ,
Proteasomal degradation of topoisomerase I is preceded by c-Jun NH2-terminal kinase activation, Fas up-regulation, and poly(ADP-ribose) polymerase cleavage in SN38-mediated cytotoxicity against multiple myeloma, Cancer Res, vol.64, pp.8746-8753, 2004. ,
Constitutive Expression of MAP Kinase Phosphatase-1 Confers Multidrug Resistance in Human Glioblastoma Cells, Cancer Res Treat, vol.44, pp.195-201, 2012. ,
AZD244 (ARRY-14288), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/ pharmacodynamic relationship, and potential for combination in preclinical models, Mol Cancer Ther, vol.6, pp.2209-2219, 2007. ,
Targeting multidrug resistance in cancer, Nat Rev Drug Discov, vol.5, pp.219-234, 2006. ,
ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases, Int J Cancer, vol.109, pp.848-854, 2004. ,
Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pump, Mol Cancer Ther, vol.12, pp.2121-2134, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00861055
Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and nonneoplastic tissues, Pancreas, vol.42, pp.707-716, 2013. ,
Expression of multidrug resistance-associated protein 2 in human gallbladder carcinoma, Biomed Res Int, p.527534, 2013. ,
ABCC2 (MRP2, cMOAT) localized in the nuclear envelope of breast carcinoma cells correlates with poor clinical outcome, Pathol Oncol Res, vol.18, pp.331-342, 2012. ,
Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients, Pathol Int, vol.62, pp.167-175, 2012. ,
Cancer biomarkers: are we ready for the prime time? Cancers (Basel), vol.2, pp.190-208, 2010. ,
Cancer biomarkers: can we turn recent failures into success?, J Natl Cancer Inst, vol.102, pp.1462-1467, 2010. ,
Van Seuningen I. A role for human MUC4 www.impactjournals.com/oncotarget mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis, Oncogene, vol.23, pp.5729-5738, 2004. ,
, , p.7
, MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression, Hum Gene Ther, vol.20, pp.831-844, 2009.
Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression, Br J Cancer, vol.101, pp.637-644, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00410436
Van Seuningen I. Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha, Biochem J, vol.402, pp.81-91, 2007. ,
Van Seuningen I. The murine Muc2 mucin gene is transcriptionally regulated by the zinc-finger GATA-4 transcription factor in intestinal cells, 43. van der Sluis M, vol.348, pp.952-960, 2000. ,